A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
about
The primary vascular dysregulation syndrome: implications for eye diseasesNeuroprotection in GlaucomaUpdate on Normal Tension GlaucomaCurrent perspective of neuroprotection and glaucomaRetinal vein occlusions: The potential impact of a dysregulation of the retinal veinsLaser speckle contrast imaging in biomedical optics.The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects.Imaging retinal blood flow with laser speckle flowmetry.The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patientsTwo-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma.Evaluation of the Effect of Hypercapnia on Vascular Function in Normal Tension Glaucoma.The association between glaucoma prevalence and supplementation with the oxidants calcium and iron.Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study.Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.Emerging drugs for ocular hypertension.Medical treatment of glaucoma: present and future.Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.Glaucomatous optic neuropathy management: the role of neuroprotective agents.Prolonged mydriasis after inadvertent topical administration of the calcium channel antagonist amlodipine: implications for glaucoma drug development.Neuroprotective therapies for glaucoma.Effects of calcium ion, calpains, and calcium channel blockers on retinitis pigmentosa.Glutamate-induced internalization of Ca(v)1.3 L-type Ca(2+) channels protects retinal neurons against excitotoxicity.Management of Blood Pressure in Patients with Glaucoma.Translational Pharmacology in Glaucoma Neuroprotection.
P2860
Q21198720-2EBCCEEE-0C53-45FE-88B0-7897A7CBF78CQ26740388-3C3135FF-6A68-4559-983E-5F39D963E641Q26740392-C0696DFD-8463-4958-856E-4E7B97BBBD3BQ26774852-E2376C4C-5D36-4DB4-A8D4-187D9EFC4D6AQ33393778-FC75A7F2-26B7-4550-A633-8912B486CE10Q33538219-49875434-41F7-4BA3-8505-FF95C50A0835Q33573975-4A98A9A1-A70D-47EA-B41B-9BD6D30EE1A9Q33717013-FBEA6234-A987-4860-BFC5-F20C5BE97988Q34156443-1F1C44C4-13B4-494D-936E-50943C5D0F34Q34179227-D77A5AF9-974E-44BB-A064-D15E5FFB1E74Q35838189-93AC0A77-DC9E-481A-9AC0-5316EEAD554DQ35865425-FC06152F-5696-4B44-9B32-E94726F7E682Q36028535-9ED2DE50-2EF9-491E-A246-9C9B53393B9CQ37734597-C7E6FC70-9E3F-4372-87AA-3819F1C7FBAFQ37847182-2F664C4D-02F2-46BD-BF23-3B35C6573973Q37870933-A58749A9-45D9-44AD-83CB-A98D5A436438Q38074311-3CE11055-F73D-4D37-A1E9-531A616BBCA1Q38193827-493F5F5A-FA9E-40D2-BF18-D6CFF9C8D899Q38206242-5C4959A2-198E-4020-B146-E74A2049A07FQ38384978-46F7C842-0511-41C3-8E60-FBFDF199AD39Q41846455-61A58D3D-0A0F-4AA7-B8FE-0D4D11973E14Q43177723-D089DC4C-6D77-4936-9A26-3180956CACCBQ50002208-4FA31E71-84F1-41EF-A374-6DD1D80C4E24Q53842256-BCDAC072-3B95-4846-ACB4-D27FC8180868
P2860
A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A placebo-controlled 3-year st ...... coma with low-normal pressure.
@ast
A placebo-controlled 3-year st ...... coma with low-normal pressure.
@en
type
label
A placebo-controlled 3-year st ...... coma with low-normal pressure.
@ast
A placebo-controlled 3-year st ...... coma with low-normal pressure.
@en
prefLabel
A placebo-controlled 3-year st ...... coma with low-normal pressure.
@ast
A placebo-controlled 3-year st ...... coma with low-normal pressure.
@en
P2093
P1433
P1476
A placebo-controlled 3-year st ...... coma with low-normal pressure.
@en
P2093
Atsuo Tomidokoro
Makoto Araie
Nobuyuki Koseki
Seiichiro Yamamoto
Tomoyuki Hasegawa
Yasuhiro Tamaki
P304
P356
10.1016/J.OPHTHA.2008.05.015
P577
2008-07-31T00:00:00Z